New research is giving scientists a better understanding of the processes in the body that can lead to cancer.

Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for patients with hormone receptor-positive metastatic breast cancer. ESR1 ...

Researchers at the Josep Carreras Leukaemia Research Institute propose a new view of cancer based on spatial hallmark ecosystems and its evolution during cancer progression. This conceptual framework ...

Cancer patients frequently experience metabolic dysfunction, leading to severe weight loss correlating with a poor prognosis. Causes for this dysfunction include malnutrition and cachexia, a systemic ...

Early menopause is more than just an end to menstruation before the age of 45—it could be a genetic signpost for heightened breast cancer risks. Kirtly Jones, MD, talks to endocrinologist Corinne Welt ...

Cancer has been one of the hardest health conditions to find a solution to in the world and Pancreatic Cancer being one among ...

Melanoma may not become steadily more dangerous with age as scientists once assumed. In a surprising discovery, researchers ...

Metastatic breast cancer subtypes and biomarkers are crucial for guiding treatment decisions and managing disease progression. ER-positive, HER2-negative breast cancer treatment often begins with ...

Lung cancer has been widely perceived as a disease that predominantly affects men. However, recent epidemiological data indicate that it is increasingly being diagnosed in women. In fact, a large ...

A study of nearly 500 domestic cats uncovered similarities between cancer gene mutations in felines and humans.